Transition from Paediatric to Adult Care in Congenital Heart Disease: A Call for Action

Fabiola Boccuto1, Rosaria Barracano2, Giulia Guglielmi3

  • 1Division of Cardiology, University Hospital Renato Dulbecco, 88100 Catanzaro, Italy.

PubMed

Insights

Transitioning congenital heart disease (CHD) patients to adult care requires structured programs. Standardized, multidisciplinary protocols are essential for lifelong health and improved outcomes in adults with CHD.

Area of Science:

  • Cardiology
  • Pediatric Medicine
  • Public Health

Background:

  • Congenital heart disease (CHD) care transition from pediatric to adult services is critical for long-term outcomes.
  • Growing adult CHD population requires lifelong, multidisciplinary care, yet continuity is often lacking.
  • Current transition programs are inconsistent, highlighting the need for standardized protocols.

Purpose of the Study:

  • To advocate for structured, standardized transition programs in congenital heart disease (CHD) care.
  • To identify essential components for optimizing outcomes during CHD care transition.
  • To emphasize the lifelong nature of CHD management and the need for integrated care.

Main Methods:

  • This review synthesizes current knowledge on CHD transition care.
  • It emphasizes a multidisciplinary, longitudinal approach integrating medical, educational, and psychosocial aspects.
  • Key domains for transition programs are identified based on existing evidence.

Main Results:

  • Structured transition programs improve patient health literacy, adherence, and self-management.
  • These programs reduce patient loss to follow-up and enhance overall care continuity.
  • Multidisciplinary involvement, including primary care, is crucial for holistic care.

Conclusions:

  • Transition in CHD care must be viewed as an essential, lifelong process.
  • Standardized, evidence-based transition protocols are urgently needed for adults with CHD.
  • Implementing such protocols will empower patients and optimize long-term clinical and psychosocial well-being.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
310
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
251
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
531
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
171
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
360
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
431